method development in pharma Options
However, it ought to be acknowledged that the non-specific adsorption and phagocytosis of SPIONs by cells cannot be avoided in clinical applications; these difficulties have to be addressed in foreseeable future magnetic focusing on experiments., 2011); (ii) to ensure the particles are biocompatible and reach the tumor place without the need of bec